Efficacy and safety of the novel GlyT1 inhibitor BI 425809 in Alzheimer’s dementia: a randomized controlled trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Efficacy and safety of the novel GlyT1 inhibitor BI 425809 in Alzheimer’s dementia: a randomized controlled trial ; volume:15 ; number:1 ; day:28 ; month:1 ; year:2023 ; pages:1-12 ; date:12.2023
Alzheimer's research & therapy ; 15, Heft 1 (28.1.2023), 1-12, 12.2023
- Creator
-
Wunderlich, Glen
Blahova, Zuzana
Garcia, Miguel
Jessen, Frank
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-023-01163-3
- URN
-
urn:nbn:de:101:1-2023040421085300878577
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wunderlich, Glen
- Blahova, Zuzana
- Garcia, Miguel
- Jessen, Frank
- SpringerLink (Online service)
Other Objects (12)
GlyT1 encephalopathy: characterization of presumably disease causing GlyT1 mutations
Dementia / Alzheimer's Disease
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions
Presenilins in Alzheimer’s disease and frontotemporal dementia
Alzheimer’s disease, dementia, and stem cell therapy
Microglial immunophenotype in dementia with Alzheimer’s pathology
Neurovascular dysfunction in vascular dementia, Alzheimer’s and atherosclerosis
Plasma cholesterol in Alzheimer’s disease and frontotemporal dementia
Multimodal deep learning for Alzheimer’s disease dementia assessment
Young-onset Alzheimer’s dementia mimicking progressive myoclonic epilepsy spectrum
Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer’s Dementia
Identification and validation of Alzheimer’s disease-related metabolic brain pattern in biomarker confirmed Alzheimer’s dementia patients
GlyT1 encephalopathy: characterization of presumably disease causing GlyT1 mutations
Dementia / Alzheimer's Disease
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions
Presenilins in Alzheimer’s disease and frontotemporal dementia
Alzheimer’s disease, dementia, and stem cell therapy
Microglial immunophenotype in dementia with Alzheimer’s pathology
Neurovascular dysfunction in vascular dementia, Alzheimer’s and atherosclerosis
Plasma cholesterol in Alzheimer’s disease and frontotemporal dementia
Multimodal deep learning for Alzheimer’s disease dementia assessment
Young-onset Alzheimer’s dementia mimicking progressive myoclonic epilepsy spectrum
Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer’s Dementia
Identification and validation of Alzheimer’s disease-related metabolic brain pattern in biomarker confirmed Alzheimer’s dementia patients
GlyT1 encephalopathy: characterization of presumably disease causing GlyT1 mutations
Dementia / Alzheimer's Disease
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions
Presenilins in Alzheimer’s disease and frontotemporal dementia
Alzheimer’s disease, dementia, and stem cell therapy
Microglial immunophenotype in dementia with Alzheimer’s pathology
Neurovascular dysfunction in vascular dementia, Alzheimer’s and atherosclerosis
Plasma cholesterol in Alzheimer’s disease and frontotemporal dementia
Multimodal deep learning for Alzheimer’s disease dementia assessment
Young-onset Alzheimer’s dementia mimicking progressive myoclonic epilepsy spectrum
Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer’s Dementia